Fused-ring compounds and use thereof as drugs

Details Fused-ring compounds and use thereof as drugs Fused-ring compounds and use thereof as drugs

2007-10-23

2007-10-23

Tucker, Zachary C (Department: 1624)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Heterocyclic carbon compounds containing a hetero ring...

C514S255050, C514S256000, C514S269000, C514S275000, C514S300000, C514S303000, C514S338000, C514S339000, C514S393000, C514S394000, C514S415000, C544S238000, C544S333000, C544S405000, C546S118000, C546S121000, C546S273400, C546S277400, C546S278100, C548S238000, C548S333500, C548S405000

Reexamination Certificate

active

10615329

ABSTRACT:
The present invention provides a fused ring compound of the following formula [I]wherein each symbol is as defined in the specification, a pharmaceutically acceptable salt thereof, and a therapeutic agent for hepatitis C, which contains this compound. The compound of the present invention shows an anti-hepatitis C virus (HCV) action based on the HCV polymerase inhibitory activity, and is useful as a therapeutic agent or prophylactic agent for hepatitis C.

REFERENCES:
patent: 3644382 (1972-02-01), Clemence et al.
patent: 3778504 (1973-12-01), Clemence et al.
patent: 4250317 (1981-02-01), Meyer et al.
patent: 4360679 (1982-11-01), Meyer et al.
patent: 5280030 (1994-01-01), Jegham et al.
patent: 5563143 (1996-10-01), Cohan et al.
patent: 5605919 (1997-02-01), Matsumori
patent: 5633388 (1997-05-01), Diana et al.
patent: 5814651 (1998-09-01), Duplantier et al.
patent: 5998398 (1999-12-01), Daluge et al.
patent: 6166219 (2000-12-01), Yamasaki et al.
patent: 6211177 (2001-04-01), Sperl et al.
patent: 6448281 (2002-09-01), Beaulieu et al.
patent: 6770666 (2004-08-01), Hashimoto et al.
patent: 7112600 (2006-09-01), Hashimoto et al.
patent: 2003/0050320 (2003-03-01), Hashimoto et al.
patent: 2004/0082635 (2004-04-01), Hashimoto et al.
patent: 2004/0097438 (2004-05-01), Hashimoto et al.
patent: 0 010 063 (1980-04-01), None
patent: 0 507 650 (1992-10-01), None
patent: 0 694 535 (1996-01-01), None
patent: 03 031264 (1991-02-01), None
patent: 06-025182 (1994-02-01), None
patent: WO96/07646 (1996-03-01), None
patent: WO96/35713 (1996-11-01), None
patent: WO97/25316 (1997-07-01), None
patent: WO97/41884 (1997-11-01), None
patent: WO97/46237 (1997-12-01), None
patent: WO98/05327 (1998-02-01), None
patent: WO98/37072 (1998-08-01), None
patent: WO98/50029 (1998-11-01), None
patent: WO98/50030 (1998-11-01), None
patent: WO98/50031 (1998-11-01), None
patent: WO99/24060 (1999-05-01), None
patent: WO99/51619 (1999-10-01), None
patent: WO 01/21634 (2001-03-01), None
patent: WO 01/47883 (2001-07-01), None
patent: WO 02/04425 (2002-01-01), None
Khaliullin et al, “Synthesis of biologically active derivatives of Xanthine and benzimidazole” Bashkirskii Khimicheskii Zhumal, vol. 4(4), pp. 59-62 (1997) as Abstracted by Caplus—STN.
Hawley's Condensed Chemical Dictionary, 12th ed., Richard J. Lewis, Sr. , © 1993 by Van Nostrand Reinhold. p. 594.
Concise Encyclopedia Chemistry, edited by Drs. Hans-Dieter Jakubke and Hans Jeschkeit, © 1993 by Walter de Gruyter & Co., p. 490.
McGraw-Hill Dictionary of Chemical Terms, 3rd ed. edited by Sybil P. Parker, © 1984 McGraw-Hill, Inc., p. 200.
Khaliullin et al, “Synthesis of biologically active derivatives of Xanthine and benzimidazole” Bashkirskii Khimicheskii Zhurnal, vol. 4(4), pp. 59-62 (1997) English Translation.
U.S. Appl. No. 60/216,084, filed Jul. 6, 2000, Beaulieu.
Behrens et al.,EMBO J., 15 (1), 12-22 (1996).
Haskell et al.,J. Med. Chem., 13 (4), 697-704 (1970).
Hori et al.,Chem. Pharm. Bull., 41 (10), 1832-1841 (1993).
Kataev et al.,Khimiko-Farmatsevticheskii Zhurnal, 30 (7), 22-24 (1996).
Kataev et al.,Pharmaceutical Chemistry Journal, 30 (7), 448-450 (1996).
Khaliullin et al.,Chemical Abstracts Service, Columbus, Ohio, Database Accession No. 129:493337 (1997).
Minami et al.,The Japanese Journal of Dermatology, 111 (7), 1075-1081 (2001).
Orjales et al.,J. Med. Chem., 40 (4), 586-593 (1997).

Affiliated with

Also associated with

Rating

Fused-ring compounds and use thereof as drugs does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Fused-ring compounds and use thereof as drugs, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Fused-ring compounds and use thereof as drugs will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3903145